RxDoctor Payments Data

Evangelia Kirimis, MD

Internal Medicine · Los Angeles, CANPI 1073755278

Payments from drug & device makers

$101in general payments, 2019–2025

Across 2 payments — averaging $50.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$68
  • Takeda Pharmaceuticals U.S.A., Inc.$33

What the payments were for

  • Education$101100%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$101 in reported general payments places this provider in the 40th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$2,427,248
Medicare patients
540
Services billed
141,378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib37$591,232
EliquisApixaban32$31,007
XareltoRivaroxaban22$23,351
Anastrozole296$7,090
Letrozole93$3,164
Tamoxifen Citrate30$859
Ibandronate Sodium23$471
Ondansetron Hcl16$160
Gabapentin17$159
Alendronate Sodium13$29

Paid to pharmacies, not to this prescriber.

Other internal medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →